The Evolving Paradigm in the Treatment of HER2 Positive Metastatic Breast Cancer
July 1st 2022Vijayakrishna Gadi, MD, PhD, provides an overview of recent advancements in the treatment of HER2+ metastatic breast cancer with special consideration for challenges in the management of patients with CNS metastases.
OncLive News Network: On Location at ASCO 2022
June 5th 2022Join us LIVE at this year's 2022 ASCO Annual Meeting! OncLive® will broadcast a series of interviews with top thought leaders in breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, and gynecologic malignancies. The experts will share their insights and reactions to the pivotal data presented during the conference.
OncLive News Network On Location: ASCO GU 2022
February 17th 2022Join us LIVE at this year's 2022 Genitourinary Cancers Symposium! OncLive® will broadcast a series of interviews with top thought leaders across cancers of the bladder, prostate, and kidney. The experts will share their insights and reactions to the pivotal data presented during the conference.
Optimizing Imaging in ER-positive Metastatic Breast Cancer to Improve Clinical Outcomes
December 22nd 2021Gary Ulaner, MD, PhD and Jeremy Force, DO discuss the role of various strategies to detect estrogen receptor (ER)-positive breast cancer, with particular focus on the role of 18F-FES-PET imaging in diagnosis and treatment of ER-positive breast cancer and in improving patient outcomes.
Experts Share Insights on NCCN Guidelines for Metastatic TNBC
December 17th 2021As part of its Speaking Out video series, CURE spoke with Rebecca Moroose, MD, from Orlando Health Cancer Institute, and Virginia G. Kaklamani, MD, from UT Health San Antonio, about the National Comprehensive Cancer Network guidelines and what they mean for patients.
OncLive News Network: On Location at ASH 2021
December 11th 2021Join us LIVE at this year's 2021 ASH Annual Meeting! OncLive® will broadcast a series of interviews with top thought leaders across hematologic malignancies. The experts will share their insights and reactions to the pivotal data presented during the conference.
Antibody-Drug Conjugates in NSCLC: Update on TROPION-PanTumor01 Data
October 22nd 2021Rebecca Suk Heist, MD, MPH, and Solange Peters, MD, PhD, discuss data updates from the TROPION-PanTumor01 study that impact the use of antibody-drug conjugates as a therapy option for patients with second-line metastatic non-small cell lung cancer.
Screening and Treatment for Lung Cancer: What's Next?
October 13th 2021The second part of the webinar Lung Cancer Screening and Treatment: What's Next? focuses on the review of lung cancer screening and treatment status amid the COVID-19 pandemic. Participating faculty include Albert Rizzo, MD, FCCP, FACP, FAASM; James L. Mulshine, MD; Andrea Borondy Kitts, MS, MPH; and Sandip Patel, MD.